Dermira to Present Data for DRM01 Acne Program at EADV Congress 2015

Dermira, Inc.

, a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and their patients, today announced that new data from its DRM01 acne program will be presented at the European Academy of Dermatology and Venereology (EADV) Congress 2015 being held October 7-11, 2015 in Copenhagen. The details of the presentation are as follows: Title: Early onset of action in a randomized, vehicle-controlled Phase 2a study of DRM01, a novel topical sebum inhibitor, in subjects with acne vulgaris Date and Time: Poster available for viewing October 7 at 8:00 a.m. CET (October 6 at 11:00 p.m. PDT) through October 10 at 11:30 a.m. CET (2:30 a.m. PDT) in the auditorium lobby of the convention center Poster ID: P0014, Abstract Number: COP15-0397